Archives

Welcome to COGR

Outstanding Questions on Section 117

Update on COGR Annual Membership Dues

F&A Document and Resource Library

Click here to view

Computing Indirect Research Costs - A Non Technical Guide for College and University Presidents

Click here to view

NACUBO Professional File. Cost of Federal Research Performed by Universities: A Call for Equity by Max Binkley

Click here to view.

Federal Updates (Archived)

Click here to view

COGR letter on the DFARS - Export-Controlled Information and Technology (ARCHIVED)

Click here to view

Tuition Caps on NIH NRSA Awards

COGR opposes proposed caps on tuition for NIH NRSA awards.
Click here to view
 

Comment letter on Department of Commerce recommendations on deemed export controls (ARCHIVED)

Click here to view

Peer Review and Information Quality - OMB Issues Final Guidelines

Proposed OMB Guidelines - COGR Comment 
Click here to view 

COGR commented on proposed peer review and information quality published by OIRA.
Click here to view
 

Bob Hardy's presentation on deemed export controls at the 2004 NACUA conference (ARCHIVED)

Click here to view
Click here to view slides

Joint Statement on Visa Problems Harming America's Scientific, Economic and Security Interests

Joint statement from twenty-five associations of higher education, science and engineering on new Visa procedures that may harm science, higher education and the nation. 
Click here to view 
 

Department of State Amendments to ITAR (ARCHIVED)

Click here to view

Summary of ITAR Dilemma (ARCHIVED)

Click here to view

Summary of ITAR Regulations (ARCHIVED)

Click here to view

Examples of University Problems (ARCHIVED)

Click here to view 

Export Control Contract Clause and Alternatives (ARCHIVED)

Click here to view

The Goal Protecting Fundamental Research (ARCHIVED)

Click here to view

Factors that Influence Facilities and Administrative Cost Rates at Research Intensive Universities

Click here to view

COGR Letter to Jonathan Breul on F&A

Click here to view

Indirect Cost Rates at Research Universities - What Accounts for Differences

Click here to view

COGR Testimony at NIH Hearings on March-in Rights

NIH has denied the request from Essential Inventions, Inc. to exercise march-in rights under The Bayh-Dole Act in connection with the pricing of Norvir, marketed by Abbott Laboratories for the treatment of patients with HIV/AIDS. The decision and related materials are available online. 
Click here to view 

Andrew Neighbour, a member of the COGR Board of Directors, delivered testimony at the NIH on march-in rights. 
Click here to view